Predictive Oncology PE Ratio 2010-2023 | POAI
Current and historical p/e ratio for Predictive Oncology (POAI) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Predictive Oncology PE ratio as of April 17, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Predictive Oncology PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-04-18 | 1.15 | 0.00 | |
| 2023-09-30 | 3.20 | $-4.62 | 0.00 |
| 2023-06-30 | 4.86 | $-4.84 | 0.00 |
| 2023-03-31 | 6.54 | $-6.86 | 0.00 |
| 2022-12-31 | 6.13 | $-7.00 | 0.00 |
| 2022-09-30 | 7.20 | $-7.60 | 0.00 |
| 2022-06-30 | 8.20 | $-8.20 | 0.00 |
| 2022-03-31 | 19.54 | $-6.20 | 0.00 |
| 2021-12-31 | 19.04 | $-7.40 | 0.00 |
| 2021-09-30 | 26.60 | $-18.20 | 0.00 |
| 2021-06-30 | 26.20 | $-25.80 | 0.00 |
| 2021-03-31 | 24.20 | $-32.00 | 0.00 |
| 2020-12-31 | 14.65 | $-48.40 | 0.00 |
| 2020-09-30 | 16.28 | $-125.80 | 0.00 |
| 2020-06-30 | 32.80 | $-142.80 | 0.00 |
| 2020-03-31 | 31.51 | $-131.60 | 0.00 |
| 2019-12-31 | 52.20 | $-155.00 | 0.00 |
| 2019-09-30 | 101.00 | $-112.20 | 0.00 |
| 2019-06-30 | 149.50 | $-124.00 | 0.00 |
| 2019-03-31 | 150.00 | $-168.00 | 0.00 |
| 2018-12-31 | 123.82 | $-156.00 | 0.00 |
| 2018-09-30 | 212.00 | $-194.00 | 0.00 |
| 2018-06-30 | 226.00 | $-188.00 | 0.00 |
| 2018-03-31 | 220.00 | $-230.00 | 0.00 |
| 2017-12-31 | 202.00 | $-242.00 | 0.00 |
| 2017-09-30 | 290.72 | $-188.00 | 0.00 |
| 2017-06-30 | 294.00 | $-220.00 | 0.00 |
| 2017-03-31 | 420.00 | $-338.00 | 0.00 |
| 2016-12-31 | 560.00 | $-896.00 | 0.00 |
| 2016-09-30 | 825.00 | $-3,314.00 | 0.00 |
| 2016-06-30 | 762.50 | $-4,650.00 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.005B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.875B | 21.62 |
| Inspire Medical Systems (INSP) | United States | $7.378B | 0.00 |
| 10x Genomics (TXG) | United States | $3.475B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.470B | 0.00 |
| Axonics (AXNX) | United States | $3.427B | 0.00 |
| Enovis (ENOV) | United States | $3.084B | 23.43 |
| Azenta (AZTA) | United States | $2.854B | 232.59 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.772B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.659B | 0.00 |
| Privia Health (PRVA) | United States | $2.118B | 93.95 |
| Schrodinger (SDGR) | United States | $1.811B | 0.00 |
| Phreesia (PHR) | United States | $1.306B | 0.00 |
| Omnicell (OMCL) | United States | $1.206B | 29.52 |
| Definitive Healthcare (DH) | United States | $0.847B | 0.00 |
| Standard BioTools (LAB) | United States | $0.757B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.497B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.329B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.316B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.308B | 0.00 |
| Pulmonx (LUNG) | United States | $0.286B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.171B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.158B | 0.00 |
| Augmedix (AUGX) | United States | $0.155B | 0.00 |
| American Well (AMWL) | United States | $0.149B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.131B | 0.00 |
| TruBridge (TBRG) | United States | $0.122B | 5.19 |
| Outset Medical (OM) | United States | $0.112B | 0.00 |
| 111 (YI) | China | $0.081B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.076B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.076B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.042B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Movano (MOVE) | United States | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| ETAO (ETAO) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
| Akili (AKLI) | United States | $0.017B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |